We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

2fue

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2fue.gif|left|200px]]
+
{{Seed}}
 +
[[Image:2fue.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2fue| PDB=2fue | SCENE= }}
{{STRUCTURE_2fue| PDB=2fue | SCENE= }}
-
'''Human alpha-Phosphomannomutase 1 with D-mannose 1-phosphate and Mg2+ cofactor bound'''
+
===Human alpha-Phosphomannomutase 1 with D-mannose 1-phosphate and Mg2+ cofactor bound===
-
==Overview==
+
<!--
-
Congenital disorder of glycosylation type 1a (CDG-1a) is a congenital disease characterized by severe defects in nervous system development. It is caused by mutations in alpha-phosphomannomutase (of which there are two isozymes, alpha-PMM1 and alpha-PPM2). Here we report the x-ray crystal structures of human alpha-PMM1 in the open conformation, with and without the bound substrate, alpha-D-mannose 1-phosphate. Alpha-PMM1, like most haloalkanoic acid dehalogenase superfamily (HADSF) members, consists of two domains, the cap and core, which open to bind substrate and then close to provide a solvent-exclusive environment for catalysis. The substrate phosphate group is observed at a positively charged site of the cap domain, rather than at the core domain phosphoryl-transfer site defined by the Asp(19) nucleophile and Mg(2+) cofactor. This suggests that substrate binds first to the cap and then is swept into the active site upon cap closure. The orientation of the acid/base residue Asp(21) suggests that alpha-phosphomannomutase (alpha-PMM) uses a different method of protecting the aspartylphosphate from hydrolysis than the HADSF member beta-phosphoglucomutase. It is hypothesized that the electrostatic repulsion of positive charges at the interface of the cap and core domains stabilizes alpha-PMM1 in the open conformation and that the negatively charged substrate binds to the cap, thereby facilitating its closure over the core domain. The two isozymes, alpha-PMM1 and alpha-PMM2, are shown to have a conserved active-site structure and to display similar kinetic properties. Analysis of the known mutation sites in the context of the structures reveals the genotype-phenotype relationship underlying CDG-1a.
+
The line below this paragraph, {{ABSTRACT_PUBMED_16540464}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 16540464 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_16540464}}
==About this Structure==
==About this Structure==
Line 33: Line 37:
[[Category: Phosphomannomutase]]
[[Category: Phosphomannomutase]]
[[Category: Protein glycosylation]]
[[Category: Protein glycosylation]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 04:19:12 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 16:13:11 2008''

Revision as of 13:13, 29 July 2008

Image:2fue.png

Template:STRUCTURE 2fue

Human alpha-Phosphomannomutase 1 with D-mannose 1-phosphate and Mg2+ cofactor bound

Template:ABSTRACT PUBMED 16540464

About this Structure

2FUE is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

The X-ray crystal structures of human alpha-phosphomannomutase 1 reveal the structural basis of congenital disorder of glycosylation type 1a., Silvaggi NR, Zhang C, Lu Z, Dai J, Dunaway-Mariano D, Allen KN, J Biol Chem. 2006 May 26;281(21):14918-26. Epub 2006 Mar 15. PMID:16540464

Page seeded by OCA on Tue Jul 29 16:13:11 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2fue"
Personal tools